Thomas de Vlaam
Investitore di Private Equity presso Pillar Co Management LLC
Posizioni attive di Thomas de Vlaam
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Investitore di Private Equity | 01/07/2022 | - |
Storia della carriera di Thomas de Vlaam
Precedenti posizioni note di Thomas de Vlaam
Società | Posizione | Inizio | Fine |
---|---|---|---|
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Amministratore Delegato | 01/09/2017 | 31/05/2022 |
Fondatore | 01/09/2017 | 31/05/2022 |
Formazione di Thomas de Vlaam
University of Groningen | Undergraduate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 3 |
Stati Uniti | 2 |
Posizioni
Private Equity Investor | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Pillar Co Management LLC
Pillar Co Management LLC Investment ManagersFinance Pillar Co Management LLC (Pillar VC) is a venture capital firm founded in 2016 by Jamie Goldstein. The firm is headquartered in Boston, Massachusetts. | Finance |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Thomas de Vlaam
- Esperienza